Truist Financial Cuts CorMedix (NASDAQ:CRMD) Price Target to $14.00

CorMedix (NASDAQ:CRMD – Free Report) had its price target trimmed by Truist Financial from $18.00 to $14.00 in a report published on Wednesday, Benzinga reports. The firm currently has a buy rating on the stock. Several other analysts have also recently issued reports on CRMD. Needham & Company LLC reduced their price objective on CorMedix […]

Related Keywords

United States ,Canada , ,Royal Bank ,Cormedix Inc ,Needham Company ,Burney Co ,Nasdaq ,Ameriprise Financial Inc ,Renaissance Technologies ,Baystate Wealth Management ,Free Report ,Truist Financial ,Get Free Report ,Wealth Management ,Ameriprise Financial ,Smedix Inc ,Cormedix Daily ,Cormedix ,Nasdaq Crmd ,Crmd ,Medical ,Lower Price Target ,Truist Financial Co ,